Table 2.
EQ-5D index by country and fibrosis stagea.
| Country | NASH disease stage |
Overall | |
|---|---|---|---|
| Early (F0–F2) | Advanced (F3–F4) | ||
| France, n | 93 | 31 | 124 |
| Mean (SD) | 0.83 (0.15) | 0.82 (0.14) | 0.83 (0.15) |
| Germany, n | 94 | 37 | 131 |
| Mean (SD) | 0.81 (0.16) | 0.64 (0.26) | 0.76 (0.21) |
| Italy, n | 160 | 54 | 214 |
| Mean (SD) | 0.85 (0.12) | 0.5 (0.41) | 0.76 (0.28) |
| Spain, n | 119 | 47 | 166 |
| Mean (SD) | 0.7 (0.3) | 0.57 (0.36) | 0.66 (0.32) |
| United States, n | 58 | 36 | 94 |
| Mean (SD) | 0.80 (0.19) | 0.67 (0.23) | 0.75 (0.22) |
| All, n | 531 | 218 | 749 |
| Mean (SD) | 0.80 (0.2) | 0.62 (0.33) | 0.75 (0.26) |
EQ-5D, EuroQOL 5-D; NASH, non-alcoholic steatohepatitis.
a
UK data (n = 20) were not used for this question because of a low response rate.